News Release: Research

May 17,  2010

Action Cycling Bike Ride Benefits AIDS Vaccine Research at Emory Vaccine Center

News Article ImageFor more information about the AV200 bicycle ride, or to donate, visit www.actioncycling.org.

More than 130 bicycle riders will join the two-day, 200-mile AIDS Vaccine 200 (AV200) ride to benefit AIDS vaccine research at the Emory Vaccine Center. The event on May 22-23 is sponsored by Action Cycling Atlanta - a volunteer-run organization. This year's ride travels from Emory to Eatonton, Ga. in the Oconee National Forest and back to Emory. Participants include individual riders and relay teams, with support from a volunteer crew.

This marks the eighth year of the Action Cycling Ride, which thus far has raised more than $500,000 for AIDS vaccine research. Thanks to its generous sponsors, Action Cycling Atlanta is able to donate 100 percent of all funds raised by participants to AIDS vaccine research. These unrestricted funds fill funding gaps that cannot be met through grant dollars alone.

"The world still desperately needs effective AIDS vaccines, and the Emory Vaccine Center is at the forefront of AIDS vaccine development," says Rafi Ahmed, PhD, director of the Emory Vaccine Center and a Georgia Research Alliance Eminent Scholar. "Our scientists are making extraordinary advances in understanding the immune system and creating vaccines to prevent and treat HIV infection."

The Emory Vaccine Center is one of the largest academic vaccine centers in the world and is renowned for its expertise in cellular immunity and immune memory. A few of the projects that have been supported by Action Cycling's annual AV200 include:

  • Development of one of the world's first preventive AIDS vaccines, currently being tested in phase II clinical trials, and development of a therapeutic vaccine expected to soon enter clinical testing.
  • Combating AIDS in Africa through prevention, counseling, and vaccine development and testing.
  • Innovative discoveries about the immune system leading to new strategies designed to fight chronic infections like HIV/AIDS.
  • Testing of potential new HIV/AIDS vaccines at The Hope Clinic of the Emory Vaccine Center in Atlanta as part of the premier National Institutes of Health HIV Vaccine Trials Network
  • At the Vaccine Center's satellite campus in New Delhi, development of an AIDS vaccine designed specifically for the strain of HIV prevalent in India.

For more information about the AV200 bicycle ride, or to donate, visit http://www.actioncycling.org

For more information about the Emory Vaccine Center, visit http://vaccines.emory.edu

###

The Robert W. Woodruff Health Sciences Center of Emory University is an academic health science and service center focused on missions of teaching, research, health care and public service.

Learn more about Emory’s health sciences:
Blog: http://emoryhealthblog.com
Twitter: @emoryhealthsci
Web: http://emoryhealthsciences.org

News Release Tools

  • Print

News Releases

The news release you are currently viewing is part of an archive of Emory health sciences press releases, dating Sept. 2008 - Dec. 2011.



To View Current Releases


Emory News Center

Emory News Center



To View News Archives


News Archives

News Archives